Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Dover Corp (DOV)

Page 1 of 2

Dover Corp (NYSE:DOV) was in 20 hedge funds’ portfolio at the end of March. DOV investors should pay attention to a decrease in enthusiasm from smart money of late. There were 20 hedge funds in our database with DOV positions at the end of the previous quarter.

At the moment, there are tons of metrics investors can use to analyze their holdings. A duo of the best are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best investment managers can beat the broader indices by a healthy amount (see just how much).

Dover Corp (NYSE:DOV)Equally as important, positive insider trading activity is another way to parse down the world of equities. Just as you’d expect, there are many reasons for an executive to get rid of shares of his or her company, but only one, very simple reason why they would buy. Various academic studies have demonstrated the useful potential of this strategy if you know what to do (learn more here).

Now, let’s take a peek at the key action regarding Dover Corp (NYSE:DOV).

Hedge fund activity in Dover Corp (NYSE:DOV)

Heading into Q2, a total of 20 of the hedge funds we track held long positions in this stock, a change of 0% from one quarter earlier. With the smart money’s sentiment swirling, there exists a few noteworthy hedge fund managers who were upping their stakes considerably.

According to our comprehensive database, Diamond Hill Capital, managed by Ric Dillon, holds the most valuable position in Dover Corp (NYSE:DOV). Diamond Hill Capital has a $195.8 million position in the stock, comprising 2.1% of its 13F portfolio. Coming in second is Michael Messner of Seminole Capital (Investment Mgmt), with a $37.6 million position; the fund has 1.8% of its 13F portfolio invested in the stock. Some other hedgies with similar optimism include Israel Englander’s Millennium Management, Matthew Tewksbury’s Stevens Capital Management and Matthew Lindenbaum’s Basswood Capital.

Since Dover Corp (NYSE:DOV) has experienced declining sentiment from the aggregate hedge fund industry, it’s easy to see that there were a few funds that decided to sell off their full holdings heading into Q2. Intriguingly, Steven Cohen’s SAC Capital Advisors said goodbye to the largest position of all the hedgies we track, comprising close to $67.4 million in stock.. Ken Griffin’s fund, Citadel Investment Group, also sold off its stock, about $6.4 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

How have insiders been trading Dover Corp (NYSE:DOV)?

Insider purchases made by high-level executives is best served when the primary stock in question has seen transactions within the past half-year. Over the last 180-day time period, Dover Corp (NYSE:DOV) has experienced zero unique insiders buying, and 4 insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Dover Corp (NYSE:DOV). These stocks are Flowserve Corporation (NYSE:FLS), Ingersoll-Rand PLC (NYSE:IR), Pentair, Ltd. Registered Share (NYSE:PNR), and Roper Industries, Inc. (NYSE:ROP). This group of stocks are the members of the diversified machinery industry and their market caps are closest to DOV’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!